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Abstract Human B£-1 is an anti-apoptotic Bcl-2 family mem-
ber. Here, we found that B£-1 was converted into a potent
death-promoting protein by green £uorescent protein (GFP) fu-
sion with its N-terminus. The transient expression of GFP-B£-1
induced cytochrome c release and triggered apoptosis in 293T
cells, which depended on the mitochondrial localization of GFP-
B£-1. Apoptosis induced by GFP-B£-1 was signi¢cantly blocked
by the pan-caspase inhibitor carbobenzoxy-Val-Ala-Asp-£uoro-
methyl ketone, but was not blocked by either Bcl-xL or B£-1.
Our ¢ndings provide a useful model for understanding the struc-
tural basis of Bcl-2 family proteins that act in an opposite way
despite sharing structural similarity between anti-apoptotic and
pro-apoptotic proteins.
/ 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
It is widely believed that Bcl-2 family proteins, character-
ized by the Bcl-2 homology (BH) domain, are central regula-
tors of apoptosis. The family can be subdivided into two
groups according to e¡ects on cell survival. One group, in-
cluding Bax, Bak, Bok, Bcl-xS, Bid, Bad, Bik, and Bim, pro-
motes apoptosis, whereas the other group, including Bcl-2,
Bcl-xL, B£-1, Bcl-w, Mcl-1, E1B-19K, and Ced-9, inhibits
apoptosis [1^3]. Interestingly, available evidence demonstrates
that the three-dimensional structures of the anti-apoptotic and
pro-apoptotic proteins are strikingly similar [4^8]. However, it
is still unclear how they function in opposing ways in the
regulation of apoptosis despite their structural similarities.
The activity of Bcl-2 family proteins can be diversely regu-
lated by post-translational modi¢cations, such as by phos-
phorylation or by cleavage by proteases. For example in the
case of phosphorylation, the loop region of Bcl-2 is phosphor-
ylated during apoptosis induced by treatment with paclitaxel,
a microtubule-stabilizing agent, and this results in the disrup-
tion of the anti-apoptotic activity of Bcl-2 [9]. Pro-apoptotic
Bad is also phosphorylated by mitochondria-anchored protein
kinase A, in the presence of survival factors. This causes Bad
to be released from mitochondria into the cytosol thereby
losing its pro-apoptotic activity [10^12].
Recent works have also demonstrated that various pro-
teases cleave several Bcl-2 family proteins producing large
C-terminal fragments with potent pro-apoptotic activity [13^
18]. For example, activated caspase-8 cleaves inactive cyto-
solic Bid into an active pro-apoptotic truncated Bid (tBid)
that translocates to mitochondria, induces the release of cyto-
chrome c and then apoptosis [16,17]. Potent anti-apoptotic
Bcl-2 and Bcl-xL are also cleaved by caspase-3 under apopto-
tic situations [13,14]. Interestingly, by removing the N-termi-
nal region, these proteins are converted into Bax-like pro-ap-
optotic proteins that further activate downstream caspases
and promote the release of cytochrome c [13,14,18]. There-
fore, post-translational modi¢cations might explain the di-
verse activity of the Bcl-2 family proteins despite their similar
structures.
Here, we report that another type of modi¢cation can re-
verse the activity of Bcl-2 family proteins. We found that
B£-1, an anti-apoptotic Bcl-2 family protein, is converted
into a pro-apoptotic protein by green £uorescent protein
(GFP) fusion with its N-terminus. The transient expression
of GFP-B£-1 fusion protein remarkably induced the cell death
of HEK 293T cells, which showed apoptotic features, such as
the formation of apoptotic bodies, condensation of chroma-
tin, and DNA fragmentation. However, the transient expres-
sion of GFP or B£-1 alone had no e¡ect on cell death. The
apoptosis induced by GFP-B£-1 was characterized by its mi-
tochondrial targeting, cytochrome c release and by a caspase-
dependent pathway. Our ¢ndings provide a new model for
furthering our understanding of the structural relation be-
tween anti-apoptotic and pro-apoptotic Bcl-2 family proteins.
2. Materials and methods
2.1. Chemicals and antibodies
Pan-caspase inhibitor carbobenzoxy-Val-Ala-Asp-£uoromethyl ke-
tone (z-VAD-fmk, 100 WM) was purchased from Calbiochem (San
Diego, CA, USA). Monoclonal anti-GFP antibody and anti-goat
horseradish peroxidase (HRP) antibody were obtained from Santa
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Cruz Biotechnology (Santa Cruz, CA, USA), anti-L-actin antibody
from Sigma (St. Louis, MO, USA), the monoclonal anti-myc 9E10.2
antibody from Invitrogen (Groningen, The Netherlands), the mono-
clonal anti-cytochrome c 7H8.2C-12 antibody from PharMingen (San
Diego, CA, USA), and anti-mouse HRP antibody was purchased
from Amersham Pharmacia (Amersham, UK).
2.2. Plasmid constructions
Parental vectors, pEGFP-C1 (Clontech, Palo Alto, CA, USA) and
pcDNA3.1 Myc, His(3)B (Invitrogen) were used to produce GFP
fusion proteins and myc-tagged proteins. Expression vectors for
GFP-B£-1, GFP-Bcl-xL, B£-1-myc, Bcl-xL-myc, and Bax-myc were
as previously described [9]. To construct expression vector for GFP-
B£-1vTM, the coding sequence for B£-1 amino acids 1^158, lacking
the C-terminal 17 amino acids, was ampli¢ed by polymerase chain
reaction (PCR) using pEGFP-B£-1 plasmid as a template, and the
following primers, 5P-GAATTCGATGACAGACTGTGAATTTG-
GATAT (sense) and 5P-TCTAGAAAAGTCATCCAGCCAGATT-
TAGGTT (antisense). The PCR product was puri¢ed, digested with
EcoRI and XbaI restriction enzymes, and subcloned into EcoRI and
XbaI sites in pEGFP-C1. All the constructs were con¢rmed by DNA
sequencing.
2.3. Transfection and apoptosis assay
Apoptosis of 293T cells was monitored following transfection with
expression plasmids. 293T cells (2U105 cells in 35-mm well) were
cultured in Dulbecco’s modi¢ed Eagle’s medium/F-12 supplemented
with 10% fetal bovine serum. After 24 h of incubation, 293T cells were
transfected using the Lipofectamine procedure (Life Technologies,
Gaithersburg, MD, USA), with 1.0 Wg of the indicated expression
plasmids. For the morphological assessment of cell death, 293T cells
were plated onto LabTek II chamber slides (Nalgen Nunc Interna-
tional, Naperville, IL, USA) at densities of 5U104 cells per well.
Twenty-four hours after transfection, cells were washed with phos-
phate-bu¡ered saline (PBS) prior to ¢xation with 4% formaldehyde.
Subsequently, cells were stained with a solution containing 1 Wg/ml of
DAPI (Calbiochem) and visualized under an Axiovert 100 inverted
epi£uorescence microscope (Carl Zeiss, Thornwood, NY, USA). Nu-
clei with rippled contours and chromatin condensation were consid-
ered to represent the apoptotic stage of 293T cells. To analyze DNA
fragmentation by agarose gel electrophoresis, cells, 24 h after trans-
fection, were scraped out and collected by centrifugation. The cell
pellet was incubated with 0.2 mg/ml proteinase K in 500 Wl of bu¡er
(100 mM Tris^HCl, pH 8.5, 5 mM EDTA, 200 mM NaCl, 0.2%
sodium dodecyl sulfate) for at least 4 h at 55‡C. DNA was precipi-
tated with an equal volume of isopropanol, treated with 0.1 mg/ml
RNase A at 37‡C, analyzed on a 2% agarose gel, and detected by
ethidium bromide staining. If necessary, z-VAD-fmk (100 WM), a pan-
caspase inhibitor, was added to the cell culture immediately following
transfection.
2.4. Confocal laser scanning microscopy
Transfected 293T cells were prepared for microcopy by staining
with 50 nM of a mitochondria-speci¢c dye, MitoTracker Red
CMXRos (Molecular Probes, Eugene, OR, USA) for 10 min in the
cell culture medium. The cells were then washed twice with PBS and
¢xed with 4% paraformaldehyde. Fixed cells were counterstained with
1 Wg/ml of DAPI (Calbiochem), and placed on microscope slides.
Images were obtained using an LSM510 (Carl Zeiss, Jena, Germany)
confocal microscope.
2.5. Analysis of cytochrome c release
Mitochondria-free cytosol was prepared as previously described [19]
with some modi¢cations. Brie£y, 24 h after transfection, 293T cells
were collected by scraping, washed twice with ice-cold PBS, suspended
in 100 Wl of extraction bu¡er (50 mM PIPES^KOH, pH 7.4, 200 mM
mannitol, 70 mM sucrose, 50 mM KCl, 5 mM EGTA, 2 mM MgCl2,
1 mM dithiothreitol and protease inhibitors), and incubated on ice for
30 min. Cells were lysed by Dounce homogenization and homogenates
were centrifuged at 100 000Ug for 15 min at 4‡C. Supernatants were
harvested and 20 Wg of protein was analyzed by Western blotting
using monoclonal anti-cytochrome c antibody. Western blot analysis
was performed as described previously [20].
3. Results
3.1. Transient expression of GFP-B£-1 induces the apoptotic
death of 293T cells
Previously, we reported on the anti-apoptotic activity of
B£-1 against anti-cancer drugs and Bax, a pro-apoptotic
Bcl-2 family protein [20,21]. However, we found that the tran-
sient expression of GFP-B£-1 fusion protein in 293T cells
promoted cell death. Twenty-four hours after transfection of
GFP-B£-1, a large number of 293T cells showed several of the
morphologic features of apoptotic cells, such as cell shrinkage
and the formation of cytoplasmic blebs and apoptotic bodies.
Finally, cells detached from the culture plate. However, B£-1
co-transfected with GFP had no e¡ect on cell death (Fig. 1A).
The transient expressions of Bcl-xL, another anti-apoptotic
Bcl-2 family homologue, or of GFP-Bcl-xL were also exam-
ined, but they had no pro-apoptotic e¡ect on 293T cells (Fig.
1A). The dead cells resulting from the transient expression of
GFP-B£-1 also showed chromatin condensation by £uores-
cence microscopy (Fig. 1B), and chromosomal DNA fragmen-
tation (Fig. 1C), hallmarks of apoptotic cell death. In order to
estimate the levels of apoptotic cells induced by GFP-B£-1, we
counted apoptotic nuclei stained with DNA-speci¢c DAPI
among GFP-positive 293T cells. The transient expression of
GFP-B£-1 resulted in the marked apoptosis of 293T cells in a
time-dependent manner (Fig. 1D). Twenty-four hours after
transfection, 50% of 293T cells were apoptotic, and more
than 70% of cells were dead 48 h after transfection. However,
transfection with the other control plasmids has no signi¢cant
e¡ects on 293T cell death (Fig. 1D).
3.2. GFP-B£-1 induces apoptosis by targeting mitochondria
The activities of pro-apoptotic Bcl-2 family members, such
as Bax, Bid, and Bak, have been associated with their regu-
lated targeting to the mitochondrial membranes [16,17,22,23].
To investigate whether the pro-apoptotic activity of GFP-
B£-1 involves mitochondrial targeting, we analyzed its subcel-
lular localization by confocal laser scanning microscopy. To
visualize mitochondria, cells were stained with MitoTracker, a
red £uorescent dye that binds speci¢cally to the mitochondrial
membrane. Microscopic observations revealed that both at an
early stage (healthy cell) and at a late stage (apoptotic cell)
after transfection, GFP-B£-1 was co-localized with Mito-
Tracker in 293T cells (Fig. 2). The GFP fusion protein of
Bcl-xL, which is known to localize to the mitochondrial mem-
brane [24], showed a similar localization (Fig. 2). Several anti-
apoptotic Bcl-2 family proteins, including B£-1, contain a
hydrophobic transmembrane (TM) domain in their C-termini,
which localizes them to speci¢c intracellular membranes. To
further investigate the e¡ect of the mitochondrial targeting of
GFP-B£-1 on its pro-apoptotic activity, we expressed GFP-
B£-1vTM (1^158), lacking a C-terminal hydrophobic stretch
of 17 amino acids. We found that GFP-B£-1vTM di¡usively
localized throughout the cytoplasm and had no pro-apoptotic
activity (Fig. 3A). Thus, these results suggested that GFP-
B£-1 induces apoptosis in 293T cells after targeting the mito-
chondrial membrane. The expression levels of GFP and GFP-
Bcl-xL protein were slightly higher than GFP-B£-1 and GFP-
B£-1vTM although the cytotoxicity was most prominent in
GFP-B£-1 protein (Fig. 3B).
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3.3. GFP-B£-1 induced the release of cytochrome c from
mitochondria
Cumulative evidence shows that the pro-apoptotic activity
of Bcl-2 family proteins appears to depend on their ability to
cause cytochrome c release from mitochondria. Thus, we ex-
amined the e¡ect of GFP-B£-1 on cytochrome c release in
293T cells. Interestingly, the transient expression of GFP-
B£-1 as well as of Bax, a pro-apoptotic control, induced cy-
tochrome c release, whereas GFP had no such e¡ect (Fig. 4A).
Therefore, these results suggested that like other pro-apopto-
tic Bcl-2 family proteins, GFP-B£-1 acts directly on mitochon-
dria to induce cytochrome c release.
3.4. GFP-B£-1 induced apoptosis through a caspase-dependent
pathway
Cytosolic cytochrome c released from mitochondria is
known to activate Apaf-1, which in turn activates caspase-9
and a downstream caspase cascade [25,26]. We examined
whether z-VAD-fmk, a general caspase inhibitor, could inhibit
the pro-apoptotic activity of GFP-B£-1. Most cells transfected
with Bax expression plasmid, as a control, and cultured in the
presence of 100 WM of z-VAD-fmk did not undergo apoptosis
without morphological changes (Fig. 4B,C). Similarly, z-VAD-
fmk also signi¢cantly blocked the cell death induced by GFP-
B£-1 (Fig. 4B,C), indicating that GFP-B£-1 induced cell death
through a caspase-dependent pathway, in part, in a manner
similar to that of the pro-apoptotic Bax.
3.5. Apoptosis induced by GFP-B£-1 is not inhibited by
anti-apoptotic Bcl-xL or B£-1
Next, we examined whether the anti-apoptotic members
Bcl-xL and B£-1 inhibit the cell death induced by GFP-
Fig. 1. The transient expression of GFP-B£-1 induces apoptotic cell death in 293T cells. A: Fluorescence observation showing the cell morphol-
ogy of 293T cells expressing GFP fusion proteins or GFP. 293T cells were co-transfected with pEGFP-B£-1 (1 Wg), pEGFP-Bcl-xL (1 Wg),
pcDNA-B£-1 (1 Wg)+pEGFP-C1 (0.1 Wg), or pcDNA-Bcl-xL (1 Wg)+pEGFP-C1 (0.1 Wg) plasmids. At 24 h after transfection, the e¡ect of
GFP-B£-1 on the cells was examined by £uorescence microscopy. B: Nuclear morphology in 293T cells transfected with pEGFP-B£-1 (1 Wg) or
pcDNA-B£-1 (1 Wg)+pEGFP-C1 (0.1 Wg) was observed after staining with DNA-speci¢c DAPI (1 Wg/ml). C: DNA fragmentation was analyzed
in cells transfected with 1 Wg of pEGFP-B£-1, pEGFP-Bcl-xL, or pcDNA-B£-1 plasmids. Twenty-four hours after transfection, DNA was ex-
tracted, electrophoresed on 2% agarose gel and visualized by ethidium bromide staining. D: Time course e¡ect of GFP-B£-1 on 293T cell
death. To quantify cell death, 293T cells were transfected with 1 Wg of plasmids and stained with DAPI at the indicated time points. Fluores-
cence microphotographs were taken of three di¡erent ¢elds each containing about 100 cells expressing GFP. Cells showing apoptotic nuclei
were considered dead. The percentages of apoptotic cells are expressed as meansSS.D.; similar results were obtained from two other indepen-
dent experiments.
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B£-1. Both proteins are known to inhibit cell death induced
by various apoptotic stimuli, such as treatment with anti-can-
cer drugs or by the expression of pro-apoptotic proteins like
Bax or Bid [27^30]. Our results showed that Bcl-xL and B£-1
are capable of suppressing Bax-induced cell death; however,
they failed to protect 293T cells from the apoptotic cell death
induced by GFP-B£-1 (Fig. 4D,E).
4. Discussion
B£-1, which consists of 175 amino acids and four conserved
BH domains (BH1^4), is known to protect cells from various
apoptotic stimuli. B£-1 suppressed tumor necrosis factor-K-
induced cell death in HeLa-derived HtAT cells [31] and in
human microvascular endothelial cells ([32]. It was also found
to suppress the cell death induced by chemotherapeutic drugs,
such as etoposide, cisplatin or adriamycin [27,28]. In addition,
we previously demonstrated that B£-1 suppresses staurospo-
rine-induced apoptosis in Reh human B-lymphoblastic cells
[21] and in Molt-4 human T-leukemia cells [20]. In Molt-4
T cells, B£-1 was found to prevent the activation of Bid and
of caspase-3, 8 and 9. B£-1 was also found to be localized at
mitochondria and to prevent mitochondrial transmembrane
potential loss when apoptosis was induced by staurosporine
[20].
However, surprisingly we found that GFP-B£-1 fusion pro-
tein strongly induced apoptotic cell death in 293T cells (Fig.
1). Previously, there were several reports that GFP has a
cytotoxic e¡ect on cells [33,34]. However, the pro-apoptotic
activity of GFP-B£-1 fusion protein was not the result of GFP
itself because the transient expression of GFP, GFP with
B£-1, or of GFP-Bcl-xL fusion protein had no e¡ect on cell
death.
Although the pro-apoptotic mechanism of GFP-B£-1 is not
clear, our results suggest that mitochondrial targeting is crit-
ical for its pro-apoptotic activity. GFP-B£-1 was predomi-
nantly localized to the mitochondria of early healthy cells or
late apoptotic cells (Fig. 2), induced cytochrome c release
(Fig. 4A), and triggered apoptotic cell death mediated by
caspase-dependent mechanisms (Fig. 4B,C). Therefore, it is
possible that GFP-B£-1, like Bax or Bak (multi-domain pro-
apoptotic Bcl-2 family proteins), might directly damage the
mitochondrial structure resulting in cytochrome c release,
and subsequent caspase activation [1^3].
The Bcl-2 family proteins are capable of physically interact-
ing with each other, to form a complex network of homo- and
Fig. 2. GFP-B£-1 fusion proteins localize at mitochondria in both healthy and apoptotic 293T cells. 293T cells were transfected with 1 Wg of
pEGFP-B£-1, pEGFP-Bcl-xL, or pEGFP-C1. Twenty-four hours after transfection, mitochondria were stained for 10 min with 50 nM of Mito-
Tracker, a mitochondria-speci¢c dye, and cells were analyzed by confocal laser microscopy. a: Cells expressing GFP. b: Cells expressing GFP-
Bcl-xL. c: Healthy cells expressing GFP-B£-1. d: Apoptotic cells expressing GFP-B£-1.
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heterodimers, via molecular regions, like the BH domains.
Moreover, these physical interactions sometimes play impor-
tant roles in the net e¡ects of pro- and anti-apoptotic mem-
bers of the family [22,35^37]. For example, cytosolic and
monomeric Bax, an inactive form, translocates to mitochon-
dria where it becomes an integral membrane protein, in a
homodimer form, that actively triggers apoptosis [22,35].
However, the coexpression of Bcl-2 or Bcl-xL with Bax was
found to neutralize the pro-apoptotic e¡ect of Bax by forming
heterodimers with Bax [36]. Recently, it was proposed that
pro-apoptotic Bid, which possesses only the BH3 domain,
cooperates with Bax to cause mitochondrial dysfunction
[37]. Previously, it was shown that B£-1, which has a Bcl-
xL-like core structure, interacted strongly with Bax and neu-
tralizes the pro-apoptotic e¡ect of Bax in yeast cells [29]. In
addition, recent evidence revealed that B£-1 selectively and
tightly binds to tBid and blocks the collaboration between
Bid and Bax [19].
Therefore, we initially postulated that GFP-B£-1 might ex-
press its pro-apoptotic e¡ect by interacting with other pro-
apoptotic proteins such as Bax or Bid, based on the interac-
tive property of B£-1. If GFP-B£-1 like B£-1 binds with Bax,
Bid or other unknown pro-apoptotic factors, the overexpres-
sion of B£-1 or of Bcl-xL could compete with GFP-B£-1, and
might inhibit the apoptotic cell death induced by GFP-B£-1.
Thus, we examined the antagonizing e¡ects of Bcl-xL or B£-1
on the apoptosis induced by GFP-B£-1. However, our results
showed that neither inhibited the apoptosis induced by GFP-
B£-1 in spite of their excess overexpression relative to GFP-
B£-1 (¢ve-fold transfection of expression plasmids), whereas
Fig. 3. The C-terminal TM domain of B£-1 is essential for the mitochondrial localization and pro-apoptotic activity of GFP-B£-1. 293T cells
were transfected with 1 Wg of pEGFP-C1, pEGFP-Bcl-xL, pEGFP-B£-1 or pEGFP-B£-1vTM (GB vTM) plasmids. Twenty-four hours after
transfection, the cells were observed under a £uorescence microscope (A) and cell death was quanti¢ed as described in Section 2 (B). The ex-
pression levels of GFP fusion proteins were examined by Western blotting with anti-GFP antibody. The percentages of apoptotic cells are ex-
pressed as meansSS.D.; similar results were obtained from three independent experiments.
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Bax-induced cell death was signi¢cantly blocked by Bcl-xL or
B£-1, which is consistent with previous observations [29,30]
(Fig. 4D,E). Thus, these results suggest that GFP fusion at
the N-terminus of B£-1 might induce a B£-1 conformational
change, which modi¢es its interactions with other proteins.
Therefore, it would be interesting in the future to examine
whether B£-1 and GFP-B£-1 interact with other pro-apopto-
tic proteins in the mitochondrial membrane in a similar man-
ner.
During apoptosis, caspases have been shown to cleave two
representative anti-apoptotic proteins, Bcl-2 and Bcl-xL, and
to produce C-terminal fragments with potent pro-apoptotic
activity [13,14]. However, little is known about the pro-apo-
ptotic mechanisms of these cleaved proteins. Recently, it was
revealed that the pro-apoptotic cleavage products of Bcl-xL,
but not full form Bcl-xL, formed cytochrome c-conducting
pores in the mitochondrial membrane in vivo and in vitro,
and destabilized lipid bilayer membranes [38]. These results
are consistent with previous observations that the three-di-
mensional structure of Bcl-xL shows structural similarities
with the pore-forming domains of diphtheria toxin and bac-
terial colicins [4]. Since molecular modeling showed that the
core structure of Bcl-xL, which consists of seven K-helices, is
similar to that of B£-1, and that both proteins share the con-
served BH1 and BH2 domains [29], B£-1 might be able to
form a cytochrome c-permeable pore in the mitochondrial
membrane when fused with GFP. Therefore, it would be in-
teresting to determine whether GFP-B£-1 can form a pore
complex in the mitochondrial membrane.
Further observations, including mitochondrial apoptotic
events, protein interactions between GFP-B£-1 and other pro-
teins, and the analysis of the conformational change induced
in B£-1 by GFP fusion, may reveal the detailed mechanisms
involved, which would provide information on the functions
of the Bcl-2 family proteins.
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